Mills C J, Northrup J L, Hullinger T G, Simmons C A, Shebuski R J, Jones D A
Cardiovascular Pharmacology, Pharmacia and Upjohn, Inc., Kalamazoo, MI 49007, USA.
Cardiovasc Res. 1996 Nov;32(5):954-61.
Restenosis is a common problem which limits the effectiveness of percutaneous transluminal coronary angioplasty (PTCA). The cellular mechanisms of restenosis appear to involve smooth muscle cell (SMC) migration to the neointima in response to mitogens and growth factors, resulting in proliferation and deposition of cells in the lumen of the vessel. An antibody directed against PDGF attenuates this response in the rat. Thus, signaling cascades induced by growth factors including PDGF may be important targets for therapeutic intervention.
Since a number of growth factors activate c-fos via the p21-ras signaling pathway, we examined c-fos expression in a time course experiment involving restenotic lesions in rat carotid arteries. Sections of arteries collected at 1, 3, 7, 14 and 28 days following balloon injury were hybridized using a fluorescein-labeled RNA probe to c-fos. Immunohistochemistry was performed with antibodies to proliferating cell nuclear antigen (PCNA) and alpha-smc actin to characterize cellular constituents of the neointima, and detect any correlation between fos expression and PCNA localization.
Expression of c-fos was low at day 1. By day 3, the media and adventitia were positively stained. At days 7 and 14, most cells in the neointima were labeled. By day 28, c-fos was expressed mainly in scattered cells along the luminal surface. Control sections revealed little labeling and confirmed specific staining by the antisense strand, PCNA localization and c-fos expression were similar at days 1, 3, 7 and 28, but at day 14 c-fos was expressed throughout the lesion, with PCNA localized mainly along the luminal edge. The majority of the cells making up the neointima stained rather intensely for alpha-smc actin, identifying them as SMCs.
Results of these experiments indicate that, while c-fos expression correlates with lesion formation, it may be associated with a cellular process distinct from proliferation in this model.
再狭窄是限制经皮腔内冠状动脉成形术(PTCA)疗效的常见问题。再狭窄的细胞机制似乎涉及平滑肌细胞(SMC)响应有丝分裂原和生长因子迁移至新生内膜,导致细胞在血管腔内增殖和沉积。一种针对血小板衍生生长因子(PDGF)的抗体可减轻大鼠的这种反应。因此,包括PDGF在内的生长因子诱导的信号级联反应可能是治疗干预的重要靶点。
由于多种生长因子通过p21 - ras信号通路激活c - fos,我们在一项涉及大鼠颈动脉再狭窄病变的时间进程实验中检测了c - fos的表达。在球囊损伤后1、3、7、14和28天收集的动脉切片,使用荧光素标记的c - fos RNA探针进行杂交。用增殖细胞核抗原(PCNA)抗体和α - smc肌动蛋白抗体进行免疫组织化学,以表征新生内膜的细胞成分,并检测fos表达与PCNA定位之间的任何相关性。
c - fos在第1天表达较低。到第3天,中膜和外膜呈阳性染色。在第7天和第14天,新生内膜中的大多数细胞被标记。到第28天,c - fos主要在沿管腔表面的散在细胞中表达。对照切片显示几乎没有标记,并通过反义链证实了特异性染色,PCNA定位和c - fos表达在第1、3、7和28天相似,但在第14天,c - fos在整个病变中表达,PCNA主要定位在沿管腔边缘。构成新生内膜的大多数细胞α - smc肌动蛋白染色相当强烈,将它们鉴定为平滑肌细胞。
这些实验结果表明,虽然c - fos表达与病变形成相关,但在该模型中它可能与不同于增殖的细胞过程有关。